# Federal Law Bars Workers Compensation Coverage for Medical Marijuana Use > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/federal-workers-compensation-cannabis-coverage-barred/ > **Published:** 2026-03-11T15:19:23-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:09:11-04:00 > **Clinical Summary:** Federal workers compensation cannabis coverage is barred by law, creating challenges for injured workers using medical marijuana despite state legalization. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyPainSafety Why This Matters Clinicians treating injured workers in states with [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) programs need to understand that federal law prevents workers’ compensation insurance from covering cannabis, creating a gap between state-level clinical recommendations and insurance reimbursement. This ruling means patients may face out-of-pocket costs for cannabis treatments even when clinically indicated, potentially affecting medication adherence and clinical outcomes. Practitioners should document cannabis recommendations carefully and counsel patients about insurance coverage limitations when considering it as part of a pain management or rehabilitation plan. Clinical Summary A Second Circuit Court of Appeals decision upheld the federal prohibition on workers’ compensation coverage for [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), reasoning that cannabis’s Schedule I classification precludes reimbursement under federal law despite its therapeutic use in some states. The ruling stems from a case involving an injured construction worker whose state-authorized medical marijuana was deemed ineligible for coverage because federal law does not recognize cannabis as having accepted medical use. This decision creates a significant gap between state-level [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) and federal regulatory frameworks, leaving injured workers in states where medical marijuana is legal potentially unable to access coverage for this treatment. Clinicians prescribing cannabis to injured workers should counsel patients that federal workers’ compensation programs are unlikely to cover these costs and advise them to clarify coverage status with their employers or insurers before beginning treatment. The decision underscores the ongoing conflict between state [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) programs and federal Schedule I classification, creating a practical barrier to cannabis access for workers who might otherwise benefit from it medically. Clinicians should document the medical rationale for cannabis recommendations thoroughly, as patients may need to pursue alternative funding or appeal denials based on state law protections. Dr. Caplan’s Take “The Schedule I classification is a legal fiction that contradicts clinical reality, and it forces me to watch patients suffer needlessly because federal law won’t acknowledge what I can demonstrate in my practice every day: cannabis has clear therapeutic applications for pain, nausea, and muscle spasms that we’ve documented across two decades of clinical use.” Clinical Perspective Despite growing state-level legalization and clinical evidence supporting cannabis for certain conditions like [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) and chemotherapy-induced nausea, federal Schedule I classification continues to create legal barriers to insurance coverage for injured workers seeking this treatment option. This 2nd Circuit decision underscores a persistent disconnect between evolving clinical evidence, state regulations, and federal policy that complicates care discussions with patients in occupational health settings. Providers should be aware that even when cannabis may be clinically appropriate or state-approved for a patient’s condition, workers’ compensation coverage remains federally prohibited, potentially limiting therapeutic options for injured workers who lack private financial resources. The distinction between clinical efficacy and legal permissibility also means that documented cannabis use could theoretically affect workplace safety assessments, drug screening policies, or return-to-work clearances. Clinicians should counsel injured patients transparently about these coverage limitations while continuing to document the clinical rationale for any recommended cannabis use 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Federal+law+bars+coverage+for+injured+worker%27s+medical+marijuana+use%2C+2nd+Circuit+says+%40drcaplan&url=https%3A%2F%2Ftoday.westlaw.com%2FDocument%2FIe39c6a591d6411f18fd8c08957994c9a%2FView%2FFullText.html%3FtransitionType%3DCategoryPageItem%26contextData%3D%28sc.Default%29)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Ftoday.westlaw.com%2FDocument%2FIe39c6a591d6411f18fd8c08957994c9a%2FView%2FFullText.html%3FtransitionType%3DCategoryPageItem%26contextData%3D%28sc.Default%29)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Federal+law+bars+coverage+for+injured+worker%27s+medical+marijuana+use%2C+2nd+Circuit+says+--+via+%40drcaplan.bsky.social+https%3A%2F%2Ftoday.westlaw.com%2FDocument%2FIe39c6a591d6411f18fd8c08957994c9a%2FView%2FFullText.html%3FtransitionType%3DCategoryPageItem%26contextData%3D%28sc.Default%29)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://today.westlaw.com/Document/Ie39c6a591d6411f18fd8c08957994c9a/View/FullText.html?transitionType=CategoryPageItem&contextData=(sc.Default)](https://today.westlaw.com/Document/Ie39c6a591d6411f18fd8c08957994c9a/View/FullText.html?transitionType=CategoryPageItem&contextData=(sc.Default)) Further Reading CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) Cannabis Policy Wire[AM Policy Update: March 11, 2026](https://cedclinic.com/dea-rescheduling-marijuana-march-11-2026/) Research Digest[AM Study Update: March 11, 2026](https://cedclinic.com/cannabis-clinical-research-2026-march-11-update/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Trump Administration Reclassifies Medical Marijuana, Marking Significant Policy Change](https://cedclinic.com/trump-administration-medical-marijuana-reclassification/) Explore how federal policy shifts impact medical marijuana classification and potential insurance coverage changes. [Read More](https://cedclinic.com/trump-administration-medical-marijuana-reclassification/) [DOJ Reschedules Medical Marijuana; States Face New Uncertainty](https://cedclinic.com/doj-medical-marijuana-rescheduling-impact-states-uncertainty/) Learn about DOJ rescheduling effects on state medical marijuana programs and insurance coverage challenges. [Learn More](https://cedclinic.com/doj-medical-marijuana-rescheduling-impact-states-uncertainty/) [After a Hard-Fought Victory to Legalise Medical Cannabis in the UK, Why Is It Still So Hard to Access?](https://cedclinic.com/after-a-hard-fought-victory-to-legalise-medical-cannabis-in-the-uk-why-is-it-still-so-hard-to-access/) Understand ongoing access barriers to [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) despite legalization, relevant to insurance and policy issues. [Discover More](https://cedclinic.com/after-a-hard-fought-victory-to-legalise-medical-cannabis-in-the-uk-why-is-it-still-so-hard-to-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).